CN105031120A - Externally applied traditional Chinese medicine for treating systematic lupus erythematosus - Google Patents
Externally applied traditional Chinese medicine for treating systematic lupus erythematosus Download PDFInfo
- Publication number
- CN105031120A CN105031120A CN201510353877.3A CN201510353877A CN105031120A CN 105031120 A CN105031120 A CN 105031120A CN 201510353877 A CN201510353877 A CN 201510353877A CN 105031120 A CN105031120 A CN 105031120A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- herba
- traditional chinese
- folium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses externally applied traditional Chinese medicine for treating systematic lupus erythematosus. The externally applied traditional Chinese medicine comprises, by weight, 9-10 parts of dried rehmannia roots, 3-4 parts of radix cyathulae, 2-4 parts of glossy privet leaves, 5-7 parts of scutellaria barbata, 4-5 parts of herba taxilli, 8-10 parts of fructus arctii, 2-4 parts of folium isatidis, 5-6 parts of celastrus angulata maxim, 3-5 parts of rhizoma menispermi, 2-4 parts of saruma henryi, 5-8 parts of harlequin glorybower leaves, 4-5 parts of palm bark, 2-4 parts of hedyotis diffusa, 1-3 parts of saussurea japonica, 2-4 parts of herba fibraureae recisae leaves, 1-2 parts of Chinese pearleaf crabapple leaves and 4-5 parts of goldhair hedyotis herb. The externally applied traditional Chinese medicine has the advantages that stasis removing, blood cooling, heat clearing, toxicity removing, healthy qi strengthening and pathogen eliminating effects can be realized by the traditional Chinese medicine composition, effects of eliminating pathogen without harming the healthy qi and strengthening the healthy qi without retaining the pathogen can be realized, good treatment effects can be realized when the externally applied traditional Chinese medicine is clinically used for treating the systematic lupus erythematosus, and the externally applied traditional Chinese medicine is low in recurrence rate and free of toxic and side effects.
Description
Technical field
The present invention relates to a kind of external application Chinese medicine of systemic lupus erythematosus, belong to the field of Chinese medicines.
Background technology
Systemic lupus erythematosus (sle) is that one involves health multisystem multiple organ, complicated clinical manifestation, course of disease delay autoimmune disease repeatedly; Western medical treatment systemic lupus erythematosus (sle) many employings hormone, cannot stability contorting, and therapeutic effect is not obvious, and it is slow to take effect; Owing to can not get effective alleviation, lupus patient stands skin lesion for a long time, arthropathy, and heart, respiratory system also can suffer damage.
Summary of the invention
The object of the present invention is to provide a kind of external application Chinese medicine of systemic lupus erythematosus.
The present invention adopts following technical scheme to achieve these goals:
The external application Chinese medicine of systemic lupus erythematosus, the weight portion of its constitutive material is: Radix Rehmanniae 9-10, Radix Cyathulae 3-4, Folium Ligustri Lucidi 2-4, Herba Scutellariae Barbatae 5-7, Herba Taxilli 4-5, Fructus Arctii 8-10, Folium Isatidis 2-4, bitterbark 5-6, Rhizoma Menispermi 3-5, Herba Asari 2-4, Folium Clerodendri Trichotomi 5-8, Fibra Trachycarpi 4-5, Herba Hedyotidis Diffusae 2-4, Herba saussureae stellae 1-3, Folium Fibraureae 2-4, Folium Mali Asiaticae 1-2 and Herba Hedyotidis Chrysotrichae 4-5.
The external application Chinese medicine of systemic lupus erythematosus, the weight portion of its constitutive material is: Radix Rehmanniae 9.5, Radix Cyathulae 3.5, the Folium Ligustri Lucidi 3, Herba Scutellariae Barbatae 6, Herba Taxilli 4.5, Fructus Arctii 9, Folium Isatidis 3, bitterbark 5.5, Rhizoma Menispermi 4, Herba Asari 3, Folium Clerodendri Trichotomi 6.5, Fibra Trachycarpi 4.5, Herba Hedyotidis Diffusae 3, Herba saussureae stellae 2, Folium Fibraureae 3, Folium Mali Asiaticae 1.5 and Herba Hedyotidis Chrysotrichae 4.5.
Herba saussureae stellae is the herb of feverfew Herba saussureae stellae; Folium Fibraureae is the blade of menispermaceous plants Caulis Fibraureae; Folium Mali Asiaticae is the leaf of rosaceous plant premium; Herba Hedyotidis Chrysotrichae is the herb of Rubiaceae plants of Hedyotis Herba Hedyotidis Chrysotrichae.
Consumption and usage: take each raw material by the weight portion of constitutive material, grind rear mix homogeneously, crosses 80-120 mesh sieve; Then add the Cera Flava of appropriate molten condition wherein, stir, make thick paste, once, within 10 days, be a course for the treatment of, general 2-4 can cure a course for the treatment of in coating every day.
Beneficial effect of the present invention:
Chinese medicine composition of the present invention has blood stasis dispelling removing heat from blood, heat-clearing and toxic substances removing, effect that righting is got rid of evils, and reaches eliminating evil and just do not hindering, and the merit of heresy is not stayed in righting, is used for the treatment of systemic lupus erythematosus (sle) clinically, and its therapeutic effect is good, and relapse rate is low, has no side effect.
Detailed description of the invention
Embodiment 1: the external application Chinese medicine of systemic lupus erythematosus, the weight portion (g) of its constitutive material is: Radix Rehmanniae 9.5, Radix Cyathulae 3.5, the Folium Ligustri Lucidi 3, Herba Scutellariae Barbatae 6, Herba Taxilli 4.5, Fructus Arctii 9, Folium Isatidis 3, bitterbark 5.5, Rhizoma Menispermi 4, Herba Asari 3, Folium Clerodendri Trichotomi 6.5, Fibra Trachycarpi 4.5, Herba Hedyotidis Diffusae 3, Herba saussureae stellae 2, Folium Fibraureae 3, Folium Mali Asiaticae 1.5 and Herba Hedyotidis Chrysotrichae 4.5.
Consumption and usage: take each raw material by the weight portion of constitutive material, grind rear mix homogeneously, crosses 80-120 mesh sieve; Then add the Cera Flava of appropriate molten condition wherein, stir, make thick paste, once, within 10 days, be a course for the treatment of, general 2-4 can cure a course for the treatment of in coating every day.
Model case:
Case 1, Chu, female, 24 years old, there is difform erythema at front and back, and shape erythema iris, butterfly erythema etc., with the symptom such as arthralgia, arthritis, apply external application Chinese medicine of the present invention, once a day, after applying two courses for the treatment of, arthralgia disappears, erythema, pain relief, after continuing three courses for the treatment of of coating, erythema disappears, and skin recovers as before.
Case 2, money, female, 58 years old, face suffers from systemic lupus erythematosus (sle) half a year, get involved symptoms such as can having poor appetite, nausea,vomiting,diarrhea, ascites, multi-treatment is invalid, rear coating external application Chinese medicine of the present invention, once a day, coating more than ten skies, symptom obviously alleviates, and continues two courses for the treatment of of coating, cure, skin recovers normal.
Case 3, permit certain, female, 35 years old, there was irregular shape erythema neck, auricle and shirtfront, and shape has erythema iris; Patient is with symptoms such as anemia, thrombocytopenia, lymphadenectasis, and apply external application Chinese medicine of the present invention, once a day, after applying two courses for the treatment of, erythema alleviates, and after continuing three courses for the treatment of of coating, cures, does not recur so far.
Claims (2)
1. an external application Chinese medicine for systemic lupus erythematosus, is characterized in that the weight portion of its constitutive material is: Radix Rehmanniae 9-10, Radix Cyathulae 3-4, Folium Ligustri Lucidi 2-4, Herba Scutellariae Barbatae 5-7, Herba Taxilli 4-5, Fructus Arctii 8-10, Folium Isatidis 2-4, bitterbark 5-6, Rhizoma Menispermi 3-5, Herba Asari 2-4, Folium Clerodendri Trichotomi 5-8, Fibra Trachycarpi 4-5, Herba Hedyotidis Diffusae 2-4, Herba saussureae stellae 1-3, Folium Fibraureae 2-4, Folium Mali Asiaticae 1-2 and Herba Hedyotidis Chrysotrichae 4-5.
2. the external application Chinese medicine of systemic lupus erythematosus according to claim 1, is characterized in that the weight portion of its constitutive material is: Radix Rehmanniae 9.5, Radix Cyathulae 3.5, the Folium Ligustri Lucidi 3, Herba Scutellariae Barbatae 6, Herba Taxilli 4.5, Fructus Arctii 9, Folium Isatidis 3, bitterbark 5.5, Rhizoma Menispermi 4, Herba Asari 3, Folium Clerodendri Trichotomi 6.5, Fibra Trachycarpi 4.5, Herba Hedyotidis Diffusae 3, Herba saussureae stellae 2, Folium Fibraureae 3, Folium Mali Asiaticae 1.5 and Herba Hedyotidis Chrysotrichae 4.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510353877.3A CN105031120A (en) | 2015-06-25 | 2015-06-25 | Externally applied traditional Chinese medicine for treating systematic lupus erythematosus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510353877.3A CN105031120A (en) | 2015-06-25 | 2015-06-25 | Externally applied traditional Chinese medicine for treating systematic lupus erythematosus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105031120A true CN105031120A (en) | 2015-11-11 |
Family
ID=54438480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510353877.3A Withdrawn CN105031120A (en) | 2015-06-25 | 2015-06-25 | Externally applied traditional Chinese medicine for treating systematic lupus erythematosus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105031120A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109172724A (en) * | 2018-11-19 | 2019-01-11 | 亳州市君臣佐使药业有限公司 | A kind of Chinese materia medica preparation and preparation method thereof for treating lupus erythematosus |
-
2015
- 2015-06-25 CN CN201510353877.3A patent/CN105031120A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109172724A (en) * | 2018-11-19 | 2019-01-11 | 亳州市君臣佐使药业有限公司 | A kind of Chinese materia medica preparation and preparation method thereof for treating lupus erythematosus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103505534B (en) | Traditional Chinese medicine composition for treating rheumatic arthralgia | |
| CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
| CN104906368A (en) | Traditional Chinese medicine composition for treating systemic lupus erythematosus | |
| CN105250693A (en) | External use traditional Chinese medicine capable of promoting wound to heal | |
| CN105031120A (en) | Externally applied traditional Chinese medicine for treating systematic lupus erythematosus | |
| CN104998202A (en) | Traditional Chinese medicine for treating cervical spondylosis | |
| CN104644857A (en) | Traditional Chinese medicine formula for treating acnes | |
| CN101167921A (en) | Medicinal composition for treating stomachache and preparation process thereof | |
| CN102988712A (en) | Traditional Chinese medicine for treating cough and preparation method of traditional Chinese medicine | |
| CN104338045A (en) | Drug for treating gynecologic inflammation and preparation method thereof | |
| CN105311372A (en) | Traditional Chinese medicine for treating arthralgia and supplementing calcium | |
| CN101791382B (en) | Chinese herbal medicine combination for treating nasal bleeding | |
| CN101716296A (en) | Traditional Chinese medicine pill for treating psoriasis | |
| CN104958569A (en) | Externally applied traditional Chinese medicine for treating rheumatic arthralgia | |
| CN103768431A (en) | Composition for treating intense toxic heat type lupus erythematosus | |
| CN103520594B (en) | Traditional Chinese medicine for treating interior dampness-heat syndrome type acne disease | |
| CN105998862A (en) | Traditional Chinese medicinal composition for treating arthralgia and myalgia | |
| CN104815056A (en) | Externally used traditional Chinese medicine for treating rheumatoid arthritis | |
| CN104873832A (en) | Traditional Chinese medicine decoction for inducing diuresis and treating stranguria | |
| CN105031319A (en) | External traditional Chinese medicine for removing scar | |
| CN105920418A (en) | Traditional Chinese medicine for treating eczema | |
| CN105434805A (en) | Traditional Chinese medicine for treating cold | |
| CN104800391A (en) | Traditional Chinese medicine for treating hepatitis | |
| CN105168991A (en) | Traditional Chinese medicinal composition for treating chronic bronchitis | |
| CN105770619A (en) | Externally-used traditional Chinese medicine for treating rheumatic arthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20151111 |